Citadel Advisors’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
460,406
-788,305
| -63% | -$481K | ﹤0.01% | 4689 |
|
|
2025
Q1 | $943K | Buy |
1,248,711
+1,228,465
| +6,068% | +$927K | ﹤0.01% | 3346 |
|
|
2024
Q4 | $19.5K | Sell |
20,246
-22,864
| -53% | -$22K | ﹤0.01% | 5649 |
|
|
2024
Q3 | $62.1K | Sell |
43,110
-469,942
| -92% | -$677K | ﹤0.01% | 5055 |
|
|
2024
Q2 | $621K | Buy |
513,052
+274,838
| +115% | +$333K | ﹤0.01% | 3559 |
|
|
2024
Q1 | $560K | Buy |
238,214
+104,985
| +79% | +$247K | ﹤0.01% | 3770 |
|
|
2023
Q4 | $252K | Buy |
133,229
+34,212
| +35% | +$64.7K | ﹤0.01% | 4397 |
|
|
2023
Q3 | $136K | Buy |
99,017
+73,498
| +288% | +$101K | ﹤0.01% | 4711 |
|
|
2023
Q2 | $62K | Sell |
25,519
-287,458
| -92% | -$699K | ﹤0.01% | 4921 |
|
|
2023
Q1 | $1.8M | Sell |
312,977
-69,071
| -18% | -$398K | ﹤0.01% | 2631 |
|
|
2022
Q4 | $3.42M | Buy |
382,048
+120,521
| +46% | +$1.08M | ﹤0.01% | 2135 |
|
|
2022
Q3 | $3.72M | Buy |
261,527
+156,986
| +150% | +$2.23M | ﹤0.01% | 2130 |
|
|
2022
Q2 | $1.53M | Buy |
104,541
+12,766
| +14% | +$186K | ﹤0.01% | 2984 |
|
|
2022
Q1 | $1.83M | Buy |
91,775
+54,127
| +144% | +$1.08M | ﹤0.01% | 3105 |
|
|
2021
Q4 | $658K | Buy |
+37,648
| New | +$658K | ﹤0.01% | 4294 |
|
|
2021
Q2 | – | Sell |
-28,422
| Closed | -$355K | – | 6347 |
|
|
2021
Q1 | $355K | Buy |
+28,422
| New | +$355K | ﹤0.01% | 4871 |
|
|
2020
Q2 | – | Sell |
-5,024
| Closed | -$36K | – | 4579 |
|
|
2020
Q1 | $36K | Buy |
+5,024
| New | +$36K | ﹤0.01% | 4583 |
|
|
2018
Q2 | – | Sell |
-1,638
| Closed | -$110K | – | 4121 |
|
|
2018
Q1 | $110K | Buy |
+1,638
| New | +$110K | ﹤0.01% | 3618 |
|